121 related articles for article (PubMed ID: 15822869)
1. [GnRH agonists versus antagonists in fertilization in vitro].
Frydman R
Rev Prat; 2005; Spec. No():30-4. PubMed ID: 15822869
[No Abstract] [Full Text] [Related]
2. GnRH agonists, antagonists, and assisted conception.
van Loenen AC; Huirne JA; Schats R; Hompes PG; Lambalk CB
Semin Reprod Med; 2002 Nov; 20(4):349-64. PubMed ID: 12536358
[TBL] [Abstract][Full Text] [Related]
3. GnRH agonists vs antagonists.
Tarlatzis BC; Kolibianakis EM
Best Pract Res Clin Obstet Gynaecol; 2007 Feb; 21(1):57-65. PubMed ID: 17049460
[TBL] [Abstract][Full Text] [Related]
4. [Gonadorelin antagonists: present and future ].
Bouchard P
Rev Prat; 2005; Spec. No():25-7. PubMed ID: 15822867
[No Abstract] [Full Text] [Related]
5. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
6. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
DiLuigi AJ; Nulsen JC
Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
[TBL] [Abstract][Full Text] [Related]
7. Are GnRH antagonists comparable to agonists for use in IVF?
Huirne JA; Homburg R; Lambalk CB
Hum Reprod; 2007 Nov; 22(11):2805-13. PubMed ID: 17872909
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of Centchroman on hypothalamo-pituitary axis in male rats.
Arbatti NJ; Sheth AR; Vaidya RA
Indian J Exp Biol; 1977 Dec; 15(12):1194-5. PubMed ID: 350766
[No Abstract] [Full Text] [Related]
9. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C
Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
[TBL] [Abstract][Full Text] [Related]
10. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands.
Heitman LH; Ijzerman AP
Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294
[TBL] [Abstract][Full Text] [Related]
11. [Analogues agonists and antagonists: what is their role outside of fertilization in vitro?].
Antoine JM; Merviel P; Alvarez S; Mandelbaum J; Salat-Baroux J; Uzan S
Gynecol Obstet Fertil; 2000 Oct; 28(10):757-9. PubMed ID: 11244639
[No Abstract] [Full Text] [Related]
12. Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles.
Wei AY; Mijal KA; Christianson MS; Schouweiler CM; Lindheim SR
J Reprod Med; 2008 Mar; 53(3):147-50. PubMed ID: 18441715
[TBL] [Abstract][Full Text] [Related]
13. GnRH antagonists in ovarian stimulation for IVF.
Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
[TBL] [Abstract][Full Text] [Related]
14. Discussion to "the neuroendocrine control of the menstrual cycle".
Knobil E
Recent Prog Horm Res; 1981; 37():703-7. PubMed ID: 6792667
[No Abstract] [Full Text] [Related]
15. Neuroendocrine regulation of reproduction.
Zárate A
Arch Invest Med (Mex); 1985; 16 Suppl 3():5-10. PubMed ID: 3939562
[No Abstract] [Full Text] [Related]
16. Overcrowding effects on the hypothalamo-pituitary axis.
Shah PG; Jayatilak PG; Sheth AR
Indian J Exp Biol; 1980 Jun; 18(6):565-7. PubMed ID: 6777290
[No Abstract] [Full Text] [Related]
17. Dynamics of pituitary down-regulation and ovarian response to controlled stimulation in in vitro fertilization cycles.
Mohamed KA; Davies WA; Lashen H
Fertil Steril; 2007 Feb; 87(2):433-5. PubMed ID: 17094983
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
19. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
Fauser BC; Devroey P
Fertil Steril; 2005 Jun; 83(6):1607-11. PubMed ID: 15950626
[TBL] [Abstract][Full Text] [Related]
20. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
